# Trade Mark Journal No.2025/044 31 October 2025

## UK00004283146 24 October 2025 (5,42,44)

EXCELLERGY

International priority date claimed: 29 May 2025 (United States of America) (99208934)

Class 5
  Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; chemical and biological diagnostic preparations and substances for clinical and medical laboratory use in drug discovery and nucleic acid and protein therapeutics.
Class 42
  Biotechnology, medical and scientific research, and development services in the field of protein therapeutics and diagnostics; biotechnology research services, namely, protein therapeutics development for applications in the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; biotechnology research services, namely, protein therapeutics development for applications in the treatment of allergies, blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; medical, pharmaceutical and scientific research and development services in the field of protein therapeutics and diagnostics.
Class 44
  Providing medical information and patient support services, namely, pharmaceutical advice and consultation in the nature of providing online information regarding pharmaceuticals and the treatment and prevention of various illnesses, disorders and maladies; providing health and medical information about pharmaceuticals; information services, namely, providing medical information to patients; providing medical consultancy and advisory services via a global computer network in the fields of pharmaceuticals and various illnesses, disorders and maladies.

Excellergy, Inc.

Representative: CMS Cameron McKenna Nabarro Olswang LLP